Drug intelligence / Profile preview

68Ga-DOTA-D-Alanine-BoroPro

Development stage
Preclinical
Lead developer
Instituto Nacional de Investigaciones Nucleares
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**68Ga-DOTA-D-Alanine-BoroPro** is an experimental **gallium-68-labeled fibroblast activation protein imaging radiopharmaceutical** developed as a PET tracer for visualization of **fibroblast activation protein** expression in malignant and non-malignant tissues. It is a DOTA-conjugated derivative of D-Alanine-BoroPro, a boronic acid-based FAP inhibitor scaffold, radiolabeled with gallium-68 for positron emission tomography. Preclinical work and first-in-human imaging reported specific recognition of FAP, rapid renal clearance, and imaging activity in glioblastoma, breast cancer, prostate cancer, and myocardial infarction, supporting its development as a targeted molecular imaging agent rather than a therapeutic drug.

Other names
gallium-68 DOTA-D-Alanine-BoroProgallium68 DOTA-D-Alanine-BoroProgallium 68 DOTA-D-Alanine-BoroPro68Ga-DOTA-D-Alanine-BoroPro68Ga-iFAP
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on 68Ga-DOTA-D-Alanine-BoroPro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-DOTA-D-Alanine-BoroPro.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call